Novo Nordisk, the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...

Some of the more than a dozen states that cover the high cost of GLP-1 drugs like Wegovy, Ozempic and Zepbound through ...

Two new studies suggest the class of weight loss and diabetes drugs that includes Ozempic and Wegovy have the added benefit ...

Emergency room visits attributed to popular weight loss drugs such as Ozempic and Wegovy remain quite rare overall, but do ...

--Novo Nordisk is considering launching its weight loss injection Wegovy in India sooner than planned to better challenge U.S. rival Eli Lilly, Reuters reports, citing unnamed sources.

Drugs like Ozempic and Wegovy could slash risk of dementia - Obesity and diabetes drugs offer a ‘protective effect’ for the ...

Dozens of trials testing GLP-1 drugs like semaglutide, the medicine in Ozempic and Wegovy, against a placebo suggest that ...

Semaglutide, the active ingredient in Novo's Wegovy and diabetes medicine Ozempic, goes off patent in India in 2026, paving ...

President Donald Trump's administration has decided not to cover expensive, high-demand obesity treatments under the ...

Advances recognized by science’s most lucrative awards include Large Hadron Collider experiments and groundbreaking ...